Vir Biotechnology

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIR and other ETFs, options, and stocks.

About VIR

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes.

CEO

Marianne de Backer

CEOMarianne de Backer

Employees

408

Employees408

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2016

Founded2016

Employees

408

Employees408

VIR Key Statistics

Market cap

675.13M

Market cap675.13M

Price-Earnings ratio

-1.21

Price-Earnings ratio-1.21

Dividend yield

—

Dividend yield—

Average volume

1.18M

Average volume1.18M

High today

$4.93

High today$4.93

Low today

$4.75

Low today$4.75

Open price

$4.75

Open price$4.75

Volume

635.24K

Volume635.24K

52 Week high

$14.45

52 Week high$14.45

52 Week low

$4.16

52 Week low$4.16

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own VIR. This list is generated using Robinhood data, and it’s not a recommendation.